
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
Adipophilin | N/A | ACI 3138 A | API 3138 AA | VLTR 3138 G20 | 1:100 | IVD | |||||
ALK [5A4] | 5A4 | ACI 3041 A | ACI 3041 B | API 3041 AA | VLTM 3041 G20 | 1:100 | IVD | ||||
Alpha-1-Fetoprotein (AFP) | N/A | CP 028 A | PP 028 AA | VLTR 028 G20 | 1:100 | IVD | |||||
AMACR (RM) | 13H4 | APA 3024 AA | VLTRZ 3024 G20 | APA 3024 H | N/A | ASR | |||||
AMACR (RM), 2X | 13H4 | APA 3016 AA | APA 3016 H | N/A | ASR | ||||||
Amyloid A | mc1 | CM 125 A | PM 125 AA | 1:50 | IVD | ||||||
Amyloid P | N/A | PP 132 AA | N/A | IVD | |||||||
Androgen Receptor | AR441 | ACI 109 A | API 109 AA | 1:100 | IVD | ||||||
Arginase-1 | EP261 (previously known as EPR6672(B)) | ACI 3058 A | ACI 3058 B | API 3058 AA AVI 3058 G | OAI 3058 T60 | VLTR 3058 G20 | 1:100 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
Bcl-2 | 100/D5 | CM 003 A | CM 003 C | PM 003 AA | IP 003 G10 | OAI 003 T60 | VLTM 003 G20 | 1:100 | IVD | ||
Bcl-6 | LN22 | CM 410 A | CM 410 C | PM 410 AA | OAI 410 T60 | VLTM 410 G20 | 1:100 | IVD | |||
Ber-EP4 | Ber-EP4 | PM 107 AA | IP 107 G10 | OAI 107 T60 | PM 107 H | N/A | IVD | ||||
Ber-EP4 + BG8 | Ber-EP4 + F3 | API 3112 AA | N/A | IVD | |||||||
β-Catenin | 14 | CM 406 A | CM 406 C | PM 406 AA | VLTM 406 G20 | 1:200 | IVD | ||||
Biotinylated Bromodeoxyuridine (BrdU) | TG14 | ACR 3042 AK | ACR 3042 CK | 1:100 | RUO | ||||||
BRCA-1 | MS110 | CM 345 A | CM 345 B | 1:50 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
c-Myc | EP121 (previously known as Y69) | CME 415 AK | CME 415 CK | PME 415 AA | 1:100 | IVD | |||||
C4d (RM) | A24-T | ACI 3134 A | ACI 3134 B | API 3134 AA | 1:100 | IVD | |||||
CA 125 | OC125 | CM 101 AK | CM 101 CK | PM 101 AA | VLTM 101 G20 | 1:100 | IVD | ||||
CA 19-9 | 121SLE | CM 123 A | PM 123 AA | 1:50 | IVD | ||||||
Calcitonin | N/A | CP 072 B | PP 072 AA | VLTR 072 G20 | 1:200 | IVD | |||||
Calponin | CALP | CM 172 A | CM 172 C | PM 172 AA | VLTM 172 G20 | 1:100 | IVD | ||||
Calretinin | N/A | CP 092 A | CP 092 C | PP 092 AA | IP 092 G10 | OAI 092 T60 | VLTR 092 G20 | 1:100 | IVD | ||
Carcinoembryonic Antigen (CEA{M}) | COL-1 | CM 058 A | CM 058 B | CM 058 C | PM 058 AA | VLTM 058 G20 | 1:100 | IVD | |||
Caspase-3 (Cleaved) | N/A | CP 229 A | CP 229 B | CP 229 C | PP 229 AA | 1:100 | IVD | ||||
CD10 | 56C6 | CM 129 AK | CM 129 BK | CM 129 CK | PM 129 AA | IP 129 G10 | OAI 129 T60 | VLTM 129 G20 | 1:100 | IVD | |
CD10 | UMAB236 | API 3212 AA | N/A | IVD | |||||||
CD103 (RM) | EP206 | ACI 3117 A | ACI 3117 B | API 3117 AA | 1:50 | IVD | |||||
CD117/c-kit | EP10 (previously known as Y145) | CME 296 AK | CME 296 BK | CME 296 CK | PME 296 AA | IP 296 G10 | OAI 296 T60 | VLTR 296 G20 | 1:50 | IVD | |
CD11c (Leu-M5) | 5D11 | ACI 3122 A | ACI 3122 B | API 3122 AA | 1:100 | IVD | |||||
CD137 | BBK-2 | ACI 3201 A | ACI 3201 B | API 3201 AA | 1:100 | IVD | |||||
CD138 | B-A38 | CM 167 AK | CM 167 BK | CM 167 CK | PM 167 AA | IP 167 G10 | VLTM 167 G20 | 1:100 | IVD | ||
CD138 + Cyclin D1 | B-A38 + SP4 | API 3193DS AA | N/A | IVD | |||||||
CD138 + Ki-67 | B-A38 + SP6 | API 3169 DS AA | N/A | IVD | |||||||
CD15 Cocktail | MMA + BY87 | CM 073 A | CM 073 B | CM 073 C | PM 073 AA | IP 073 G10 | OAI 073 T60 | 1:50 | IVD | ||
CD15 [MMA] | MMA | CM 029 A | CM 029 C | PM 029 AA | 1:100 | IVD | |||||
CD163 | 10D6 | CM 353 AK | CM 353 CK | PM 353 AA | OAI 353 T60 | 1:100 | IVD | ||||
CD19 | CD19 | CM 310 A | CM 310 B | PM 310 AA | 1:100 | IVD | |||||
CD1a [O10] | O10 | ACI 3158 A | ACI 3158 B | API 3158 AA | VLTM 3158 G20 | 1:100 | IVD | ||||
CD20 (P) | N/A | ACR 3004 A | ACR 3004 B | 1:100 | RUO | ||||||
CD20 [L26] | L26 | CM 004 A | CM 004 B | CM 004 C | PM 004 AA | IP 004 G10 | OAI 004 T60 | IP 004 G20, VLTM 004 G20 | PM 004 H | 1:100 | IVD |
CD21 | 2G9 | CM 142 A | CM 142 C | PM 142 AA | OAI 142 T60 | 1:50 | IVD | ||||
CD22 [BLCAM/1796] | BLCAM/1796 | ACI 3229 B | API 3229 AA | 1:100 | IVD | ||||||
CD23 | 1B12 | CM 100 A | CM 100 C | PM 100 AA | OAI 100 T60 | VLTM 100 G20 | 1:100 | IVD | |||
CD3 (P) | N/A | CP 215 A | CP 215 C | PP 215 AA | VLTR 215 G20 | 1:100 | IVD | ||||
CD3 | EP41 (previously known as EP449E; also identified as E272 in this product) | CME 324 A | CME 324 B | CME 324 C | PME 324 AA | 1:50 | IVD | ||||
CD3 T-Cell (M) | PS1 | CM 110 AK | CM 110 BK | CM 110 CK | PM 110 AA, VP 110 G | IP 110 G10 | OAI 110 T60 | VLTM 110 G20 | PM 110 H | 1:100 | IVD |
CD3 [BC33] | BC33 | ACI 3170 A | ACI 3170 C | API 3170 AA | 1:100 | IVD | |||||
CD3 [LN10] | LN10 | ACI 3152 A | ACI 3152 C | API 3152 AA | VLTM 3152 G20 | API 3152 H | 1:50 | IVD | |||
CD30 (Ki-1) | Ber-H2 | PM 031 AA | PM 031 H | N/A | IVD | ||||||
CD30 (Ki-1) | CON6D/B5 | CM 346 A | CM 346 B | CM 346 C | PM 346 AA | 1:100 | IVD | ||||
CD30 Cocktail | BerH2 + Con6D/B5 | PM 074 AA | VLTM 074 G20 | N/A | IVD | ||||||
CD31 (PECAM-1) | BC2 | CM 347 A | CM 347 C | PM 347 AA | 1:200 | IVD | |||||
CD31 (PECAM-1) | JC/70A | CM 131 A | CM 131 C | PM 131 AA | OAI 131 T60 | 1:50 | IVD | ||||
CD31 | Mec13.3 | CM 303 A | CM 303 B | 1:50-1:100 | RUO | ||||||
CD33 | PWS44 | ACI 3116 A | ACI 3116 C | API 3116 AA | VLTM 3116 G20 | 1:50 | IVD | ||||
CD34 | QBEnd/10 | CM 084 A | CM 084 B | CM 084 C | PM 084 AA | IP 084 G10 | OAI 084 T60 | VLTM 084 G20 | PM 084 H | 1:100 | IVD |
CD4 (RM) | EP204 | API 3209 AA | VLTR 3209 G20 | N/A | IVD | ||||||
CD4 + CD8 | 4B12 + SP16 | API 3157 DS AA | N/A | IVD | |||||||
CD4 [4B12] | 4B12 | ACI 3148 A | ACI 3148 C | API 3148 AA | VLTM 3148 G20 | 1:100 | IVD | ||||
CD43 | DF-T1 | CM 005 A | CM 005 C | PM 005 AA | IP 005 G10 | 1:100 | IVD | ||||
CD44 | BC8 | PM 380 AA | N/A | IVD | |||||||
CD44 | 156-3C11 | CM 318 A | CM 318 B | PM 318 AA | 1:100 | IVD | |||||
CD45RO [UCHL-1] | UCHL-1 | CM 006 B | CM 006 C | PM 006 AA | 1:100 | IVD | |||||
CD5 (M) | 4C7 | CM 099 A | CM 099 C | PM 099 AA | OAI 099 T60 | 1:100 | IVD | ||||
CD56 | BC56C04 | CM 164 A | CM 164 B | CM 164 C | PM 164 AA | OAI 164 T60 | VLTM 164 G20 | 1:100 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
CD57 (Natural Killer Cell) | NK-1 | CM 007 B | CM 007 C | PM 007 AA | OAI 007 T60 | 1:100 | IVD | ||||
CD68 [KP1] | KP1 | CM 033 A | CM 033 B | CM 033 C | PM 033 AA | IP 033 G10 | OAI 033 T60 | 1:100 | IVD | ||
CD7 | LP15 | CM 158 AK | CM 158 BK | CM 158 CK | PM 158 AA | OAI 158 T60 | VLTM 158 G20 | 1:100 | IVD | ||
CD71 | H68.4 | ACI 3110 A | ACI 3110 B | API 3110 AA | 1:100 | IVD | |||||
CD79a | HM47/A9 | CM 067 A | CM 067 C | PM 067 AA | VLTM 067 G20 | 1:100 | IVD | ||||
CD8 | SP16 | CRM 311 A | CRM 311 C | PRM 311 AA | VLTR 311 G20 | 1:50 | IVD | ||||
CD8 | C8/144B | ACI 3160 A | ACI 3160 C | API 3160 AA | VLTM 3160 G20 | 1:100 | IVD | ||||
CD99 | EP8 (previously known as EPR3097Y) | CME 392 A | PME 392 AA | OAI 392 T60 | VLTR 392 G20 | 1:50 | IVD | ||||
CDH17 (M) | 1H3 | ACI 3111 A | ACI 3111 C | API 3111 AA AVI 3111 G |
VLTM 3111 G20 | 1:100 | IVD | ||||
CDX2 | CDX2-88 | CM 226 A | CM 226 B | CM 226 C | PM 226 AA | IP 226 G10 | OAI 226 T60 | VP 226 G | PM 226 H | 1:100 | IVD |
CDX2 (M) + CDH17 (RM) | CDX-88 + EP86 | API 3135DS AA | N/A | IVD | |||||||
CDX2 (RM) | EP25 | ACI 3144 A | ACI 3144 B | API 3144 AA | VLTR 3144 G20 | 1:100 | IVD | ||||
CDX2 + CK7 | CDX2-88 + BC1 | PM 367 DS AA | PM 367 DS H | N/A | IVD | ||||||
CDX2 [BC39] | BC39 | ACI 3184 A | ACI 3184 C | API 3184 AA AVI 3184 G |
1:100 | IVD | |||||
Chromogranin A | LK2H10 + PHE5 | CM 010 A | CM 010 B | CM 010 C | PM 010 AA | IP 010 G10 | OAI 010 T60 | VLTM 010 G20 | 1:100 | IVD | |
CK8/18 (RM) | EP17+EP30 | API 3161 AA | N/A | IVD | |||||||
CK HMW + p63 + AMACR (RM) | 34βE12 + 4A4 + 13H4 | API 3154DS AA | IPI 3154DS G10 | OAI 3154 T60 | VLTMR 3154 G20 | API 3154DS H | N/A | IVD | |||
CK5 + p63 | XM26 + 4A4 | PM 235 AA | PM 235 H | N/A | IVD | ||||||
CK5/14 + p63 + CK7/18 | XM26+LL002 + 4A4 + BC1+EP30 | PM 360 DS AA | OAI 360 T60 | VLTMR 360 G20 | PM 360 DS H | N/A | IVD | ||||
CK5/14 + p63 + P504S | XM26+LL002 + 4A4 + N/A | PPM 225 AA | PPM 225 H | N/A | IVD | ||||||
CK5/14 + p63 + P504S | XM26+LL002 + 4A4 + N/A | PPM 225 DS AA | IPR 225DS G10 | PPM 225 DS H | N/A | RUO | |||||
Claudin-4 | 3E2C1 | ACI 3121 A | ACI 3121 B | API 3121 AA | 1:100 | IVD | |||||
Clusterin | 41D | ACI 218 A | 1:200 | IVD | |||||||
Collagen IV | Col 94 | CM 112 B | PM 112 AA | 1:100 | IVD | ||||||
COX-2 | SP21 | CRM 306 A | PRM 306 AA | 1:50 | IVD | ||||||
CTLA-4 | UMAB249 | ACI 3211 A | ACI 3211 B | API 3211 AA | 1:100 | IVD | |||||
CTLA-4 | CAL49 | ACI 3220 A | ACI 3220 B | API 3220 AA | 1:100 | IVD | |||||
Cyclin D1 | EP12 | CME 432 A | CME 432 C | PME 432 AA | OAI 432 T60 | VLTR 432 G20 | 1:100 | IVD | |||
Cyclin D1 | SP4 | CRM 307 AK | CRM 307 BK | CRM 307 CK | PRM 307 AA | IPI 307 G10 | 1:50 | IVD | |||
Cytokeratin 14 (CK14) | LL002 | CM 185 B | CM 185 C | 1:100 | IVD | ||||||
Cytokeratin 17 (CK17) | Ks 17.E3 | PM 176 AA | N/A | IVD | |||||||
Cytokeratin 18 (CK18) | DC10 | ACI 3061 A | ACI 3061 C | API 3061 AA | VLTM 3061 G20 | 1:100 | IVD | ||||
Cytokeratin 19 (CK19) | Ks19.1 | CM 242 A | CM 242 C | PM 242 AA | OAI 242 T60 | 1:100 | IVD | ||||
Cytokeratin 20 (CK20) | Ks20.8 | CM 062 A | CM 062 C | PM 062 AA | IP 062 G10 | OAI 062 T60 | VLTM 062 G20 | PM 062 H | 1:100 | IVD | |
Cytokeratin 5 (CK5) | XM26 | CM 234 A | CM 234 C | PM 234 AA | OAI 234 T60 | VLTM 234 G20 | 1:50 | IVD | |||
Cytokeratin 5 (CK5) | EP42 (previously known as EP1601Y) | CME 430 A | CME 430 B | PME 430 AA | VLTR 430 G20 | 1:100 | IVD | ||||
Cytokeratin 5/14 Cocktail | XM26 + LL002 | ACI 3025 A | ACI 3025 C | API 3025 AA | OAI 3025 T60 | VLTM 3025 G20 | 1:100 | IVD | |||
Cytokeratin 5/6 (CK 5/6) | CK5/6.007 | CM 105 A | CM 105 B | CM 105 C | PM 105 AA | IPI 105 G0 | VLTM 105 G20 | 1:100 | IVD | ||
Cytokeratin 7 (CK7) | BC1 | CRM 339 A | CRM 339 C | PRM 339 AA | IP 339 G10 | VLTR 339 G20 | 1:100 | IVD | |||
Cytokeratin 7 (CK7) | OV-TL 12/30 | CM 061 A | CM 061 B | CM 061 C | PM 061 AA | IPI 061 G10 | OAI 061 T60 | VLTM 061 G20 | 1:100 | IVD | |
Cytokeratin HMW [34βE12] | 34βE12 | CM 127 A | CM 127 C | PM 127 AA | IPI 127 G10 | OAI 127 T60 | VLTM 127 G20 | PM 127 H | 1:100 | IVD | |
Cytokeratin LMW (8/18) | 5D3 | CM 056 A | CM 056 C | PM 056 AA | IP 056 G10 | OAI 056 T60 | VLTM 056 G20 | PM 056 H | 1:100 | IVD | |
Cytokeratin [AE1] LMW | AE1 | PM 081 AA | N/A | IVD | |||||||
Cytomegalovirus (CMV) | DT10 + BC90 | ACA 118 A | ACA 118 B | ACA 118 C | APA 118 AA | VLTMZ 118 G20 | 1:100 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
D2-40 (Lymphatic Marker) | D2-40 | CM 266 A | CM 266 B | CM 266 C | PM 266 AA | IP 266 G10 | OAI 266 T60 | 1:100 | IVD | ||
Desmin | D33 | CM 036 A | CM 036 B | CM 036 C | PM 036 AA | IP 036 G10 | OAI 036 T60 | 1:20 | IVD | ||
Desmoglein 3 | BC11 | CM 419 A | CM 419 C | PM 419 AA | VLTM 419 G20 | 1:100 | IVD | ||||
Desmoglein 3 + CK5 | BC11 + XM26 | ACI 3018 A | ACI 3018 C | API 3018 AA | 1:100 | IVD | |||||
Desmoglein 3 + Napsin A | BC11 + N/A | PPM 428DS AA | N/A | IVD | |||||||
Desmoglein 3 + p40 (M) | BC11 + BC28 | API 3067 AA | N/A | IVD | |||||||
Desmoglein 3 + p40 (M) + Napsin A (RM) | BC11 + BC28 + BC15 | API 3132DS AA | N/A | IVD | |||||||
DOG1 | DOG1.1 | CM 385 A | CM 385 C | PM 385 AA | OAI 385 T60 | VLTM 385 G20 | 1:100 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
E-Cadherin (RM) | EP6 (previously known as EP700Y) | ACI 3012 A | ACI 3012 C | API 3012 AA | VLTR 3012 G20 | 1:50 | IVD | ||||
E-cadherin | HECD-1 | CM 170 A | CM 170 C | PM 170 AA | IP 170 G10 | VLTM 170 G20 | 1:100 | IVD | |||
E-Cadherin | CDH1/2208R | ACI 3230 A | ACI 3230 C | API 3230 AA | 1:100 | IVD | |||||
Epidermal Growth Factor Receptor (EGFR) | H11 | ACI 063 AK | ACI 063 CK | 1:100 | IVD | ||||||
Epithelial Membrane Antigen (EMA | Mc-5 | CM 143 A | CM 143 B | CM 143 C | PM 143 AA | 1:200 | IVD | ||||
Epithelial Membrane Antigen (EMA) | E29 | ACI 3038 A | ACI 3038 C | API 3038 AA | 1:100 | IVD | |||||
Epstein-Barr Virus (EBV) | EBV01, 02, and 03 | APA 111 AA | VLTMZ 111 G20 | N/A | ASR | ||||||
ERCC1 | 4F9 | ACI 3147 A | ACI 3147 B | 1:100 | IVD | ||||||
ERG | 9FY | CM 421 A | CM 421 C | PM 421 AA VP 421 G | OAI 421 T60 | 1:100 | IVD | ||||
ERG (M), 2X | 9FY | API 3017 AAK | N/A | IVD | |||||||
ERG-2 (ERG + CK5) | 9FY + EP42 | API 437DS AA | VLTMR 437 G20 | N/A | IVD | ||||||
Estrogen Receptor (ER) | 1D5 | ACA 054 A | ACA 054 C | APA 054 AA | VLTMZ 054 G20 | 1:100 | ASR | ||||
Estrogen Receptor (ER) | 6F11 + SP1 | APA 308 AA | VLTMRZ 308 G20 | APA 308 H | N/A | ASR | |||||
Estrogen Receptor (ER) | 6F11 | ACA 093 C | APA 093 AA | VLTMZ 093 G20 | 1:100 | ASR | |||||
Estrogen Receptor (ER) [ | SP1 | ACA 301 A | ACA 301 B | ACA 301 C | APA 301 AA | OAA 301 T60 | APA 301 H | 1:100 | ASR |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
Factor VIII | N/A | CP 039 A | CP 039 B | PP 039 AA | 1:1000 | IVD | |||||
Factor XIIIa | E980.1 | CM 357 AK | CM 357 CK | PM 357 AA | IP 357 G10 | 1:100 | IVD | ||||
Folate Receptor alpha IHC Assay Kit | 26B3.F2 | N/A | IVD | ||||||||
Follicle Stimulating Hormone (FSH) | FSH03 | CM 411 A | CM 411 C | PM 411 AA | 1:200 | IVD | |||||
FOXP3 | 236A/E7 | API 3164 AA | N/A | IVD | |||||||
FOXP3 | 86D | ACI 3197 A | ACI 3197 C | API 3197 AA | 1:100 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
Galectin-3 | GAL3-3B8 | ACI 3174 A | ACI 3174 B | API 3174 AA | 1:100 | IVD | |||||
GATA-3 | L50-823 | CM 405 A | CM 405 B | PM 405 AA | OAI 405 T60 | VLTM 405 G20 | 1:100 | IVD | |||
GATA-3 + Uroplakin II | L50-823 + BC21 | API 3173 AA AVI 3173 G | N/A | IVD | |||||||
GCDFP-15 + Mammaglobin | D6 (GCDFP-15) and 31A5 (Mammaglobin) | PM 317 DS AA | N/A | IVD | |||||||
GITR [CAL8] | CAL8 | ACI 3221 A | ACI 3221 B | API 3221 AA | 1:100 | IVD | |||||
Glial Fibrillary Acidic Protein (GFAP{P}) | N/A | CP 040 A | CP 040 B | PP 040 AA | 1:100 | IVD | |||||
Glial Fibrillary Acidic Protein (GFAP{M}) | GA-5 | CM 065 A | CM 065 C | PM 065 AA | VLTM 065 G20 | 1:100 | IVD | ||||
GLUT-1 | SPM498 | CM 408 A | CM 408 B | PM 408 AA | 1:100 | IVD | |||||
Glutamine Synthetase | 6/Glutamine Synthetase | ACI 3009 A | ACI 3009 B | API 3009 AA | 1:100 | IVD | |||||
Glypican-3 | 1G12 | CM 396 A | CM 396 B | PM 396 AA | VLTM 396 G20 | 1:100 | IVD | ||||
Granzyme B | 11F1 | ACI 3202 A | ACI 3202 B | API 3202 AA | 1:50 | IVD | |||||
Gross Cystic Disease Fluid Protein-15 (GCDFP-15) | D6 | CM 113 A | CM 113 B | PM 113 AA | IP 113 G10 | 1:50 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
Heat Shock Protein 70 | W27 | CM 407 A | 1:200 | IVD | |||||||
Helicobacter pylori | BC7 | CM 383 A | CM 383 C | PM 383 AA | IP 383 G10 | OAI 383 T60 | VLTM 383 G20 | PM 383 H | 1:100 | IVD | |
Hepatocyte Specific Antigen (HSA) | OCH1E5 | CM 166 A | CM 166 C | PM 166 AA | OAI 166 T60 | 1:100 | IVD | ||||
HIF-1 alpha | EP1215Y | CME 349 A | CME 349 B | 1:100 | IVD | ||||||
HMB45 | HMB45 | CM 057 A | CM 057 B | CM 057 C | PM 057 AA | IP 057 G10 | OAI 057 T60 | VLTM 057 G20 | 1:100 | IVD | |
HMB45 + MART-1 + Tyrosinase | HMB45 + M2-7C10 + M2-9E3 + T311 | CM 165 B | CM 165 C | PM 165 AA VP165 G | IPI 165 G10 | VLTM 165 G20 | PM 165 H | 1:100 | IVD | ||
HMW CK + p63 (Basal Cell Cocktail) | XM26 + LL002 + 4A4 | CM 210 C | PM 210 AA | VLTM 210 G20 | 1:100 | IVD | |||||
HPV Cocktail Broad Spectrum (HPV-1, 6, 11, 16, 18 and 31) | BPV-1/1H8 + CAMVIR-1 | CM 177 CK | PM 177 AA | VLTMX 177 G20 | 1:100 | IVD | |||||
HPV-16 | CAMVIR-1 | CM186 C | 1:100-1:200 | RUO | |||||||
Human Chorionic Gonadotropin (Beta) | N/A | CP 124 A | PP 124 AA | VLTR 124 G20 | 1:200-1:400 | IVD | |||||
Human IgG | RWP49 | ACI 3185 A | ACI 3185 B | API 3185 AA | 1:100 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
IDO1 | UMAB126 | ACI 3210 A | ACI 3210 B | API 3210 AA | 1:100 | IVD | |||||
IGF-1R | BC10 | CM 414 A | CM 414 C | 1:100 | IVD | ||||||
IgG4 (M) | HP6025 | ACI 3115 A | ACI 3115 B | API 3115 AA | 1:100 | IVD | |||||
IMP3 (RM) | EP286 | ACI 3180 A | ACI 3180 B | API 3180 AA | 1:100 | IVD | |||||
Inhibin, Alpha | BC/R1 | CM 171 A | CM 171 B | CM 171 C | PM 171 AA | 1:100 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
Kappa (M) + Lambda (P) | L1C1 + N/A | API 3159 DS AA | VLTMR 3159 G20 | N/A | IVD | ||||||
Kappa Light Chain | L1C1 | ACI 3149 A | ACI 3149 C | API 3149 AA | VLTM 3149 G20 | 1:100 | IVD | ||||
Ki-67 | SP6 | CRM 325 A | CRM 325 B | CRM 325 C | PRM 325 AA | OAI 325 T60 | PRM 325 H | 1:50 | IVD | ||
Ki-67 + Caspase-3 | DVB-2 | PPM 240 DS AA | N/A | IVD | |||||||
Ki-67 + CK7/8/18 | MIB-1 + BC1 + EP17 + EP30 | API 3192DS AA | N/A | IVD | |||||||
Ki-67 + pHH3 | MIB-1 + BC37 | API 3198DS AA | N/A | IVD | |||||||
Ki-67 [MIB-1] | MIB-1 | API 3156 AA | VLTM 3156 G20 | API 3156 H | N/A | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
L26 + CD3 | L26 + SP7 | PM 237 DS AA | N/A | IVD | |||||||
LAG3 [CAL26] | CAL26 | ACI 3213 A | ACI 3213 B | API 3213 AA | 1:100 | IVD | |||||
Lambda Light Chain | N10/2 | ACI 3063 A | ACI 3063 C | API 3063 AA | VLTM 3063 G20 | 1:100 | IVD | ||||
Leukocyte Common Antigen (LCA) Cocktail | PD7/26 and 2B11 | CM 016 AK | CM 016 BK | CM 016 CK | PM 016 AA | IP 016 G10 | OAI 016 T60 | VLTM 016 G20 | 1:100 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
Mammaglobin (M) | 1A5 | PM 269 AA | OAI 269 T60 | VLTM 269 G20 | PM 269 H | N/A | IVD | ||||
MART-1 + Tyrosinase + pHH3 | M2-7C10 + M2-9E3 + T311 + BC37 | API 3186DS AA | N/A | IVD | |||||||
MART-1 + Tyrosinase + SOX10 | M2-7C10 + M2-9E3 + T311 + BC34 | API 3165 AA | N/A | IVD | |||||||
MART-1 + Tyrosinase + SOX10 | M2-9E3 + T311 + BC34 | AVI 3216 G | N/A | IVD | |||||||
MART-1 Cocktail | M2-7C10 + M2-9E3 | CM 077 A | CM 077 B | CM 077 C | PM 077 AA | IP 077 G10 | OAI 077 T60 | VLTM 077 G20 | PM 077 H | 1:100 | IVD |
MASH1 | 24B72D11.1 | ACI 3131 A | API 3131 AA | 1:50 | IVD | ||||||
MCM2 + TOP2A | OTI8A11 + UMAB146 | API 3181 AA | API 3181 H | N/A | IVD | ||||||
Melan A (M) | A103 | ACI 3114 A | ACI 3114 B | API 3114 AA | VLTM 3114 G20 | 1:25 | IVD | ||||
Melanoma Cocktail | HMB45 + M2-7C10 + M2-9E3 | CM 078 B | CM 078 C | PM 078 AA VP 078 G | VLTM 078 G20 | 1:100 | IVD | ||||
Mesothelin | MSLN-15C11 | ACI 3175 A | ACI 3175 B | API 3175 AA | 1:100 | IVD | |||||
Microglia (Iba1) | N/A | CP 290 A | CP 290 B | 1:200 | IVD | ||||||
Microphthalmia Transcription Factor (MiTF) | 34CA5 | CM 423 BK | PM 423 AA | 1:25 | IVD | ||||||
MLH-1 | G168-15 | CM 220 AK | CM 220 BK | CM 220 CK | PM 220 AA AVI 220 G | IPI 220 G10 | OAI 220 T60 | PM 220 H | 1:100 | IVD | |
MLH-1 | BC23 | ACI 3214 A | ACI 3214 C | API 3214 AA | API 3214 H | 1:100 | IVD | ||||
MOC-31 | MOC-31 | CM 403 A | CM 403 C | PM 403 AA | 1:200 | IVD | |||||
MSH2 | FE11 | CM 219 AK | CM 219 BK | CM 219 CK | PM 219 AA AVI 219 G | OAI 219 T60 | PM 219 H | 1:100 | IVD | ||
MSH6 | 44 (previously known as BC/44) | CM 265 AK | CM 265 BK | CM 265 CK | "PM 265 AA, AVI 265 G | IPI 265 G10 | OAI 265 T60 | PM 265 H | 1:100 | IVD | |
MSH6 [BC19] | BC19 | ACI 3215 A | ACI 3215 C | API 3215 AA | API 3215 H | 1:100 | IVD | ||||
MUC-1 | 695 | CM 319 B | PM 319 AA | 1:100 | IVD | ||||||
Mucin 5AC (Gastric Mucin) | 45M1 | CM 231 A | 1:100 | IVD | |||||||
MUM-1 | BC5 | CRM 352 A | CRM 352 B | PRM 352 AA | OAI 352 T60 | VLTR 352 G20 | 1:100 | IVD | |||
Muscle Specific Actin (MSA) | HHF35 | CM 079 A | CM 079 B | PM 079 AA | IP 079 G10 | OAI 079 T60 | VLTM 079 G20 | 1:50 | IVD | ||
Mycobacterium tuberculosis (TB) | N/A | CP 140 A | CP 140 C | PP 140 AA | 1:200 | RUO | |||||
Myeloperoxidase (P) | N/A | PP 023 AA | VLTR 023 G20 | PP 023 H | N/A | IVD | |||||
Myogenin | MyG007 (also known as F5D) | CM 115 A | CM 115 C | PM 115 AA | VLTM 115 G20 | 1:100 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
Napsin A | TMU-Ad 02 | CM 388 AK | CM 388 CK | PM 388 AA | IPI 388 G10 | OAI 388 T60 | VLTM 388 G20 | 1:100 | IVD | ||
Napsin A | N/A | PP 434 AA | VLTR 434 G20 | N/A | IVD | ||||||
Napsin A (RM) | BC15 | ACI 3043 A | ACI 3043 C | API 3043 AA | VLTR 3043 G20 | 1:100 | IVD | ||||
Nerve Growth Factor Receptor (NGFR) | EP31 (previously known as EP1039Y) | ACI 369 A | 1:50 | IVD | |||||||
Neurofilament | 2F11 | CM 066 A | CM 066 B | PM 066 AA | 1:100 | IVD | |||||
NKX3.1 | N/A | CP 422 A | CP 422 B | PP 422 AA | 1:100 | IVD | |||||
NKX3.1 (RM) | EP356 | ACI 3189 A | ACI 3189 B | API 3189 AA | 1:50 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
p120 + E-cadherin | 98/pp120 + EP6 | API 3011DS AA | VLTMR 3011 G20 | N/A | IVD | ||||||
p120 Catenin | 98/pp120 | ACI 3008 A | ACI 3008 B | API 3008 AA | VLTM 3008 G20 | 1:100 | IVD | ||||
p16 INK4a | 10 | APA 3228 AA | N/A | ASR | |||||||
p16 INK4a [BC42] | BC42 | ACI 3231 A | ACI 3231 C | API 3231 AA AVI 3231 G | VLTM 3231 G20 | 1:100 | IVD | ||||
p40 (M) | BC28 | ACI 3066 A | ACI 3066 C | API 3066 AA AVI 3066 KG | H IPI 3066 G10 | OAI 3066 T60 | VLTM 3066 G20 | API 3066 H | 1:100 | IVD | |
p40 (M), 3X (Prostate) | BC28 | N/A | IVD | ||||||||
p40 (P) | N/A | ACI 3030 A | ACI 3030 B | API 3030 AA | VLTR 3030 G20 | 1:100 | IVD | ||||
P504S (P) | N/A | ACA 200 A | ACA 200 B | ACA 200 C | "APA 200 AA AVA 200 G | IPA 200 G10 | AVA 200 G25 | APA 200 H | 1:100 | ASR | |
P504S (AMACR) (RM) | 13H4 | AVA 3207 G | N/A | ASR | |||||||
P504S-2X | PP 365 AA | IP 365 G10 | PP 365 H | N/A | ASR | ||||||
p53 | EP9 (previously known as Y5) | CME 298 AK | CME 298 BK | PME 298 AA | IP 298 G10 | VLTR 298 G20 | 1:100 | IVD | |||
p53 Tumor Suppressor Protein (M) | DO-7 | CM 042 C | PM 042 AA | VLTM 042 G20 | 1:100 | IVD | |||||
p63 | 4A4 | CM 163 A | CM 163 B | CM 163 C | PM 163 AA VP 163 G | IP 163 G10 | OAI 163 T60 | VLTM 163 G20 | PM 163 H, VP 163 G25 | 1:100 | IVD |
p63 + CK5 | 4A4 + EP42 | PM 391DS AA | VLTMR 391 G20 | N/A | IVD | ||||||
p63 + P504S | 4A4 + N/A | PPM 201 AA VP 201 G | IPR 201 G10 | PPM 201 H, VP 201 G25 | N/A | IVD | |||||
p63 + TRIM29 | 4A4 + N/A | PPM 427DS AA | VLTMR 427 G20 | N/A | IVD | ||||||
p63, 2X (Lung) | 4A4 | API 3070 AA | N/A | IVD | |||||||
p63-2X | 4A4 | PM 366 AAK | PM 366 HK | N/A | IVD | ||||||
Pan Cytokeratin Plus | AE1/AE3 + 5D3 | CM 162 A | CM 162 B | CM 162 C | PM 162 AA | IP 162 G10 | OAI 162 T60 | VLTM 162 G20 | PM 162 H | 1:100 | IVD |
Pan Cytokeratin | AE1/AE3 | CM 011 A | CM 011 B | CM 011 C | PM 011 AA, VP 011 G | IPI 011 G10 | VLTM 011 G20 | PM 011 H, VP 011 G25 | 1:100 | IVD | |
Pan Cytokeratin | Lu-5 | CM 043 C | PM 043 AA VP 043 G | IP 043 G10 | VLTM 043 G20 | 1:100 | IVD | ||||
Pan Lymphoma Cocktail (LCA+CD20+CD3+CD43) | PD7/26/16 + 2B11 + L26 + PS1 + DF-T1 | API 3035 AA | N/A | IVD | |||||||
Pan Melanoma + Ki-67 | M2-7C10 + M2-9E3 + T311 + SP6 | PM 362 DS AA | VLTMR 362 G20 | PM 362 DS H | N/A | IVD | |||||
Pan Melanoma Cocktail-2 (MART-1 and Tyrosinase) | M2-7C10 + M2-9E3 + T311 | CM 178 A | PM 178 AA | OAI 178 T60 | VLTM 178 G20 | 1:100 | IVD | ||||
PAX5 | 24 (Previously known as BC/24) | CM 207 A | CM 207 B | CM 207 C | PM 207 AA | OAI 207 T60 | VLTM 207 G20 | 1:100 | IVD | ||
PAX8 | N/A | CP 379 AK | CP 379 CK | PP 379 AA | VLTR 379 G20 | 1:200 | IVD | ||||
PAX8 (M) | BC12 | ACI 438 A | ACI 438 B | ACI 438 C | API 438 AA AVI 438 G | OAI 438 T60 | VLTM 438 G20 | 1:100 | IVD | ||
PD-1 | NAT105 | ACI 3137 AK | ACI 3137 CK | API 3137 AA | VLTM 3137 G20 | 1:100 | IVD | ||||
PD-1 (RM) | EP239 | API 3162 AA | VLTR 3162 G20 | N/A | IVD | ||||||
PD-1 | CAL20 | ACI 3224 A | ACI 3224 B | API 3224 AA | 1:100 | IVD | |||||
PD-L1 | CAL10 | ACI 3171 A | ACI 3171 C | API 3171 AA | VLTR 3171 G20 | 1:100 | IVD | ||||
pHH3 (RM) | BC37 | ACI 3130 A | ACI 3130 C | API 3130 AA | 1:100 | IVD | |||||
PHOSPHO-EGFR | EP774Y | API 300 AA | N/A | IVD | |||||||
Phospho-Histone H3 | N/A | CP 404 A | CP 404 C | PP 404 AA | 1:100 | IVD | |||||
Placental Alkaline Phosphatase (PLAP) | SP15 | CRM 350 A | CRM 350 C | PRM 350 AA | 1:100 | IVD | |||||
PMS2 | A16-4 | CM 344 AK | CM 344 BK | "PM 344 AA AVI 344 G | IPI 344 G10 | OAI 344 T60 | PM 344 H | 1:100 | IVD | ||
Progesterone Receptor (PR) | 16 | ACA 424 A | ACA 424 C | OAA 424 T60 | 1:100 | ASR | |||||
Progesterone Receptor (PR) [ | PgR636 | APA 343 AA | IPA 343 G10 | VLTMZ 343 G20 | APA 343 H | N/A | ASR | ||||
Progesterone Receptor (PR) | SP2 | ACA 302 A | ACA 302 C | APA 302 AA | VLTRZ 302 G20 | 1:100 | ASR | ||||
Prostate Cocktail - 2X (CK5 + CK14 + p63) | XM26 + LL002 + 4A4 | PM 364 AAK | IP 364 G10 | PM 364 HK | N/A | IVD | |||||
Prostate Cocktail (CK5 + CK14 + p63) | XM26 LL002 4A4 | AVI 3206 G | N/A | IVD | |||||||
Prostate Specific Antigen (PSA) | EP109 (previously known as EP1588Y) | CME 390 AK | CME 390 CK | PME 390 AA | OAI 390 T60 | VLTR 390 G20 | 1:100 | IVD | |||
Prostein | 10E3 | ACI 3163 A | ACI 3163 B | API 3163 AA | 1:100 | IVD | |||||
Prostein + PSA + NKX3.1 | 10E3 + ER-PR8 + N/A | API 3166 AA | N/A | IVD | |||||||
PTEN (Tumor Suppressor) | 6H2.1 | CM 278 AK | CM 278 BK | PM 278 AA | VLTM 278 G20 | 1:200 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
ROR gamma T | 6F3.1 | ACI 3208 A | ACI 3208 B | API 3208 AA | 1:100 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
S100 Protein | 15E2E2 | CM 128 A | CM 128 C | PM 128 AA | VLTM 128 G20 | 1:100 | IVD | ||||
S100 Protein | 4C4.9 | ACI 3237 A | ACI 3237 C | API 3237 AA | VLTM 3237 G20 | API 3237 H | 1:100 | IVD | |||
S100P | N/A | ACI 3010 A | ACI 3010 B | API 3010 AA | VLTR 3010 G20 | 1:100 | IVD | ||||
SALL4 | 6E3 | CM 384 A | CM 384 C | OAI 384 T60 | 1:100 | IVD | |||||
SATB2 | EP281 | ACI 3225 A | ACI 3225 B | API 3225 AA | 1:100 | IVD | |||||
Smooth Muscle Actin (SMA) | 1A4 (also known as asm-1) | CM 001 A | CM 001 B | CM 001 C | PM 001 AA | IP 001 G10 | OAI 001 T60 | VLTM 001 G20 | PM 001 H | 1:100 | IVD |
Smooth Muscle Myosin Heavy Chain | SMMS-1 | CM 420 A | CM 420 B | PM 420 AA | 1:100 | IVD | |||||
Smoothelin | R4A | CM 372 A | CM 372 C | PM 372 AA | VLTM 372 G20 | 1:100 | IVD | ||||
SOX10 (M) | BC34 | ACI 3099 A | ACI 3099 C | API 3099 AA AVI 3099 G | IPI 3099 G10 | OAI 3099 T60 | VLTM 3099 G20 | API 3099 H, AVI 3099 H | 1:100 | IVD | |
SOX11 (M) | SOX11-C1 | ACI 3120 A | ACI 3120 C | API 3120 AA | VLTM 3120 G20 | 1:100 | IVD | ||||
SOX2 | BC36 | ACI 3109 A | ACI 3109 C | API 3109 AA | 1:100 | IVD | |||||
Synaptophysin | 27G12 | CM 371 AK | CM 371 CK | PM 371 AA | IP 371 G10 | OAI 371 T60 | VLTM 371 G20 | 1:100 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
Terminal Deoxynucleotidyl Transferase (TdT {P} | N/A | CP 134 AK | CP 134 CK | PP 134 AA | VLTR 134 G20 | 1:100 | IVD | ||||
Thyroglobulin Cocktail | 2H11+6E1 | CM 022 A | PM 022 AA | IP 022 G10 | 1:100 | IVD | |||||
Thyroid Stimulating Hormone (TSH) | TSH01 + TSH02 | CM 412 A | CM 412 B | PM 412 AA | 1:200 | IVD | |||||
TIA-1 | TIA-1 | CM 130 A | CM 130 B | CM 130 C | PM 130 AA | VLTM 130 G20 | 1:100 | IVD | |||
Topoisomerase II alpha | 31 | ACI 3045 A | ACI 3045 B | API 3045 AA | 1:100 | IVD | |||||
Treponema pallidum (Spirochete) | N/A | ACA 135 A | ACA 135 B | ACA 135 C | APA 135 AA | IPA 135 G10 | OAA 135 T60 | VLTRZ 135 G20 | 1:100 | ASR | |
TRIM29 | N/A | PP 416 AA | N/A | IVD | |||||||
TTF-1 | 8G7G3/1 | CM 087 A | CM 087 B | CM 087 C | PM 087 AA | IP 087 G10 | VLTM 087 G2 | PM 087 H | 1:100 | IVD | |
TTF-1 + CK5 | 8G7G3/1 + EP42 | PM 425DS AA | N/A | IVD | |||||||
TTF-1 + Napsin A (RM) | 8G7G3/1 + BC15 | API 3078 DS AA | N/A | IVD | |||||||
TTF-1 [SPT24] | SPT24 | ACI 3126 A | ACI 3126 C | API 3126 AA | OAI 3126 T60 | VLTM 3126 G20 | 1:100 | IVD | |||
Tumor Associated Glycoprotein | B72.3 | CM 002 B | CM 002 C | PM 002 AA | VLTM 002 G20 | 1:100 | IVD | ||||
Tyrosinase | T311 | CM 155 A | CM 155 B | CM 155 C | PM 155 AA | OAI 155 T60 | VLTM 155 G20 | 1:100 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
Uro-2™ (CK20 + p53) | Ks20.8 + EP9 (previously known as Y5) | API 3001DS AA | N/A | IVD | |||||||
URO-3 Triple Stain (CD44 + p53) with CK20 | BC8 (CD44) EP9 (previously known as Y5) (p53) Ks20.8 (CK20) | PM 370 TS AA | N/A | IVD | |||||||
Uroplakin II | BC21 | ACI 3051 A | ACI 3051 C | "API 3051 AA AVI 3051 KG | OAI 3051 T60 | VLTM 3051 G20 | 1:100 | IVD | |||
Uroplakin II + Uroplakin III | BC21 + BC17 | API 3094 AA | VLTM 3094 G20 | N/A | IVD | ||||||
Uroplakin III | BC17 | ACI 3023 A | ACI 3023 C | API 3023 AA | VLTM 3023 G20 | 1:100 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
VEGF | EP1176Y | CME 356 AK | CME 356 BK | 1:100 | RUO | ||||||
Vimentin | V9 | CM 048 A | CM 048 C | PM 048 AA | IP 048 G10 | OAI 048 T60 | 1:100 | IVD | |||
Vimentin | SP20 | CRM 312 A | CRM 312 B | PRM 312 AA | 1:50 | IVD |
ANTI-BODY | KLON | 0.1ML KONSANTRE | 0.5ML KONSANTRE | 1ML KONSANTRE | 6ML KULLANIMA HAZIR | 10 ML KULLANIMA HAZIR (İNTELLİPATH) | 60 TEST KULLANIMA HAZIR (ONCERE) | 20 ML KULLANIMA HAZIR(VALENT) | 25ML KULLANIMA HAZIR | DİLÜSYON ORANLARI | KULLANIM AMACI |
---|---|---|---|---|---|---|---|---|---|---|---|
ZAP-70 (LR) | BC.2F3.2 | ACI 259 A | 1:100 | IVD |